Evidence map›Paper›PMID 36743871›Full record

ArticleEuropean heart journal. Digital health2023

Smartphone-based cardiac implantable electronic device remote monitoring: improved compliance and connectivity.

Harish Manyam, Haran Burri, Ruben Casado-Arroyo, Niraj Varma, Carsten Lennerz, Didier Klug, Gerald Carr-White, Kranthi Kolli, Ignacio Reyes, Yelena Nabutovsky and 1 more

Open access · goldAbstract read
In one paragraph

Article in European heart journal. Digital health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. The digital journey: 25 years of digital development in electrophysiology from an Europace perspective.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Review
  12. Remote monitoring of cardiac implantable electronic devices and disease management.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  13. Article
  14. New insertable cardiac monitors show high diagnostic yield and good safety profile in real-world clinical practice: results from the international prospective observational SMART Registry.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Observational
  15. 2023 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Practical Management of the Remote Device Clinic.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 7 countries.

Harish ManyamDepartment of Cardiovascular Medicine, University of Tennessee College of Medicine Chattanooga, 979 East Third Street, Suite C-520, Chattanooga, TN 37403, USA.
Haran BurriCardiac Pacing Unit, Cardiology Department, University Hospital of Geneva, Rue Gabrielle Perret Gentil 4, 1205 Geneva, Switzerland.ORCID https://orcid.org/0000-0002-4393-5338
Ruben Casado-ArroyoDepartment of Cardiology, Université Libre de Bruxelles, 1070 Bruxelles, Belgium.ORCID https://orcid.org/0000-0002-3876-6074
Niraj VarmaCleveland Clinic Heart and Vascular Institute, Cleveland, OH, USA.ORCID https://orcid.org/0000-0003-2296-2596
Carsten LennerzDepartment of Electrophysiology, German Heart Centre Munich, 80636 Munich, Germany.ORCID https://orcid.org/0000-0002-1693-6474
Didier KlugDepartment of Cardiology, University Hospital of Lille, 59037 Lille, France.
Gerald Carr-WhiteDepartment of Cardiology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Kranthi KolliAbbott, Global Data Science and Analytics, CA 95054, USA.ORCID https://orcid.org/0000-0002-8424-0727
Ignacio ReyesAbbott, Global Data Science and Analytics, CA 95054, USA.
Yelena NabutovskyAbbott, Global Data Science and Analytics, CA 95054, USA.
Giuseppe BorianiCardiology Division, Department of Biomedical Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy.ORCID https://orcid.org/0000-0002-9820-4815
Abbott (United States) · USCleveland Clinic · USDeutsches Herzzentrum München · DEGuy's and St Thomas' NHS Foundation Trust · GBLille’s Cardiology Hospital · FRUniversité Libre de Bruxelles · BEUniversity Hospital of Geneva · CHUniversity of Modena and Reggio Emilia · ITUniversity of Tennessee at Chattanooga · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Remote monitoring (RM) is the standard of care for follow up of patients with cardiac implantable electronic devices. The aim of this study was to compare smartphone-based RM (SM-RM) using patient applications (myMerlinPulse™ app) with traditional bedside monitor RM (BM-RM). Methods and results: The retrospective study included de-identified US patients who received either SM-RM or BM-RM capable of implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators (Abbott, USA). Patients in SM-RM and BM-RM groups were propensity-score matched on age and gender, device type, implant year, and month. Compliance with RM was quantified as the proportion of patients enrolling in the RM system (Merlin.net™) and transmitting data at least once. Connectivity was measured by the median number of days between consecutive transmissions per patient. Of the initial 9714 patients with SM-RM and 26 679 patients with BM-RM, 9397 patients from each group were matched. Remote monitoring compliance was higher in SM-RM; significantly more patients with SM-RM were enrolled in RM compared with BM-RM (94.4 vs. 85.0%, Conclusion: In this large real-world study, patients with SM-RM demonstrated improved compliance and connectivity compared with BM-RM.

Indexed as

BluetoothCardiac implantable electronic devicesComplianceConnectivityPatient-initiated transmissionsRadio frequency

Identifiers

PMID36743871
PMCPMC9890086
OpenAlexW4308918563

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.